Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,771.50
+9.50 (0.34%)
Nov 11, 2026, 9:05 AM JST
Rohto Pharmaceutical Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥3,404. The average 1-year stock price forecast is 22.81% higher than the current stock price, while the lowest is ¥2,800 (+1.03%) and the highest is ¥3,840 (+38.55%).
Price Target: ¥3,404 (+22.81%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ¥3,350 | Buy | Maintains | ¥3,350 | +20.87% | Oct 22, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 25, 2026 |
Financial Forecast
Revenue This Year
373.48B
from 343.73B
Increased by 8.66%
Revenue Next Year
391.18B
from 373.48B
Increased by 4.74%
EPS This Year
161.97
from 145.29
Increased by 11.48%
EPS Next Year
171.53
from 161.97
Increased by 5.90%
Financial currency is JPY.